Such biomarkers play pivotal roles in early detection, differential diagnosis, risk assessment, therapy monitoring, and prognosis evaluation of sepsis, including 28 day mortality [23]: procalcitonin (PCT) [24,25], soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) [8,9], the soluble form of the urokinase plasminogen activator receptor (suPAR) [9,26], highly sensitive C-reactive protein (hsCRP) [27,28], interleukin-6 (IL-6) [24,29,30], and azurocidin 1 (AZU1) [23,31]. This evidence concerns the gene AZU1 and Sepsis.